Teva says higher dose of MS drug no more efficient

 07.07.2008 03:02   reuters.com

(Reuters) - Teva Pharmaceutical Industries Ltd said data from a late-stage trial showed an increased dose of its multiple sclerosis drug, glatiramer acetate (GA), was not more efficient than an approved lower-dose version of the drug.

World Health & Beauty